Raphael Pharmaceutical Inc. Proceeds from Common Stock Issued
Raphael Pharmaceutical Inc. (RAPH) reported Proceeds from Common Stock Issued of $243.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2026-08-14
- Raphael Pharmaceutical Inc. proceeds from issuance of common stock for the quarter ending 2025-12-31 was $3.00K.
- Raphael Pharmaceutical Inc. proceeds from issuance of common stock for the quarter ending 2025-09-30 was $0.00.
- Raphael Pharmaceutical Inc. proceeds from issuance of common stock for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- Raphael Pharmaceutical Inc. proceeds from issuance of common stock for the quarter ending 2025-03-31 was $240.00K, a 33.33% increase year-over-year.
- Raphael Pharmaceutical Inc. proceeds from issuance of common stock for fiscal 2025 was $243.00K, a 13.21% decline from fiscal 2024.
- Raphael Pharmaceutical Inc. proceeds from issuance of common stock for fiscal 2024 was $280.00K, a 75.55% decline from fiscal 2023.
- Raphael Pharmaceutical Inc. proceeds from issuance of common stock for fiscal 2023 was $1.15M.
| Period end | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|
| 2025-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $3.00K derived: sum of 2 quarters · filed 2026-03-31 | $3.00K derived: sum of 3 quarters · filed 2026-08-14 | $243.00K 10-K · filed 2026-03-31 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2026-08-14 | $240.00K 10-Q · filed 2025-11-13 | $240.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $240.00K 10-Q · filed 2026-08-14 | $240.00K derived: sum of 3 quarters · filed 2026-08-14 | $240.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $240.00K 10-Q · filed 2026-05-14 | $240.00K derived: sum of 2 quarters · filed 2026-05-14 | $240.00K derived: sum of 3 quarters · filed 2026-05-14 | $340.00K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $0.00 derived: sum of 2 quarters · filed 2026-03-31 | $100.00K derived: sum of 3 quarters · filed 2026-03-31 | $280.00K 10-K · filed 2026-03-31 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $100.00K derived: sum of 2 quarters · filed 2025-11-13 | $280.00K 10-Q · filed 2025-11-13 | $299.00K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $280.00K 10-Q · filed 2025-08-13 | $299.00K derived: sum of 3 quarters · filed 2025-08-13 | $1.11M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $180.00K 10-Q · filed 2025-05-15 | $199.00K derived: sum of 2 quarters · filed 2025-05-15 | $1.01M derived: sum of 3 quarters · filed 2025-05-15 | |
| 2023-12-31 | $19.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $831.00K derived: sum of 2 quarters · filed 2025-03-31 | $1.15M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $812.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $1.13M 10-Q · filed 2024-11-14 | ||
| 2023-06-30 | $314.00K 10-Q · filed 2024-08-12 | |||
| 2022-09-30 | $112.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $424.00K 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | $312.00K 10-Q · filed 2023-08-09 | |||
| 2021-09-30 | $470.00K 10-Q · filed 2021-11-16 | |||
| 2020-09-30 | $297.00K 10-Q · filed 2021-11-16 |